Curative Biotechnology, Inc. (OTCMKTS:CUBT) Short Interest Up 487.9% in April

Curative Biotechnology, Inc. (OTCMKTS:CUBT) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 19,400 shares, an increase of 487.9% from the March 31st total of 3,300 shares. Based on an average trading volume of 678,300 shares, the short-interest ratio is currently 0.0 days.

Curative Biotechnology Trading Down 9.7 %

OTCMKTS CUBT traded down $0.00 during trading hours on Friday, reaching $0.03. 76,000 shares of the company’s stock traded hands, compared to its average volume of 223,270. Curative Biotechnology has a 52-week low of $0.01 and a 52-week high of $0.04. The firm has a 50-day simple moving average of $0.03 and a 200 day simple moving average of $0.02.

About Curative Biotechnology

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.